Literature DB >> 23564792

miRNA expression profiles of oral squamous cell carcinomas.

Katalin Gombos1, Róbert Horváth, Eszter Szele, Krisztina Juhász, Katalin Gocze, Károly Somlai, Gábor Pajkos, István Ember, Lajos Olasz.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) development involves complex machinery of genomic and epigenetic regulations including microRNA (miRNA) expression changes. We aimed to analyze the expression patterns of a set of miRNAs in human TNM stage I and II OSCC samples in an autologous normal mucosa-controlled experimental design.
MATERIALS AND METHODS: Forty samples of OSCC and 40 matched normal tissues were evaluated for miR-21, miR-155, miR-191, miR-146a, miR-221 and miR-222 expression in a LightCycler 480(PCR) system.
RESULTS: Our results showed significant overexpression of miR-21, miR-155, miR-191 and miR-221 in paired-sample t-test and the sensitivity/specificity of tests were over 90% in the case of miR-21 and miR-155 on the receiver operating characteristic curve (ROC) analysis.
CONCLUSION: Our results underline the role of miR-21 in OSCC and support the possible causal role of miR-155 and miR-221 in oral carcinogenesis. The overexpression of miR-191 is a novel finding in squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564792

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  30 in total

1.  Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.

Authors:  Rui Zhang; Bo Pang; Tao Xin; Hua Guo; Yi Xing; Shangchen Xu; Bin Feng; Bin Liu; Qi Pang
Journal:  Mol Neurobiol       Date:  2015-01-31       Impact factor: 5.590

2.  Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus - a short report.

Authors:  Masoumeh Mehdipour; Minoo Shahidi; Soheila Manifar; Soudeh Jafari; Fatemeh Mashhadi Abbas; Mahmood Barati; Hamed Mortazavi; Mohammad Shirkhoda; Amir Farzanegan; Zahra Elmi Rankohi
Journal:  Cell Oncol (Dordr)       Date:  2018-02-26       Impact factor: 6.730

3.  Radiation-induced circulating miRNA expression in blood of head and neck cancer patients.

Authors:  Francesca Pasi; Franco Corbella; Ambrogia Baio; Enrica Capelli; Annalisa De Silvestri; Carmine Tinelli; Rosanna Nano
Journal:  Radiat Environ Biophys       Date:  2020-02-10       Impact factor: 1.925

4.  The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers.

Authors:  Lijun Shen; Zhihong Wan; Yuming Ma; Libing Wu; Fangfang Liu; Hong Zang; Shaojie Xin
Journal:  Tumour Biol       Date:  2014-11-28

5.  Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.

Authors:  F Momen-Heravi; A J Trachtenberg; W P Kuo; Y S Cheng
Journal:  J Dent Res       Date:  2014-04-09       Impact factor: 6.116

Review 6.  Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.

Authors:  Guy R Adami; Jessica L Tang; Michael R Markiewicz
Journal:  Oral Oncol       Date:  2017-04-17       Impact factor: 5.337

7.  Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo.

Authors:  Yin Wang; Yu Zhu; Pin Lv; Longjiang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

8.  The role of miR-21 in proliferation and invasion capacity of human tongue squamous cell carcinoma in vitro.

Authors:  Yin Wang; Yu Zhu; Pin Lv; Longjiang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

9.  Comparative miRNA Expression Profile Analysis of Squamous Cell Carcinoma and Peritumoral Mucosa from the Meso- and Hypopharynx.

Authors:  Eva Orosz; Katalin Gombos; Tamas Riedling; Priscilla Afiakurue; Istvan Kiss; Jozsef Pytel; Imre Gerlinger; Istvan Szanyi
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

10.  Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.

Authors:  Shaan Sarkar; Hala Dubaybo; Shadan Ali; Priscila Goncalves; Sri Lakshmi Kollepara; Seema Sethi; Philip A Philip; Yiwei Li
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.